The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to explore whether the non-synonymous single-nucleotide polymorphisms in SCN9A gene can predict individual basal pain perception and postoperative pain intensity in the general population undergoing upper abdominal surgery. Methods: Patients receiving elective upper abdominal surgery under general anesthesia were recruited into this study. Genotyping of SCN9A was carried out by direct sequencing. The investigators measured their preoperative pressure pain threshold (PPT) and pressure pain tolerance (PTO). The visual analog scale (VAS) was used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 0 h, 12 h ,24 h and 48h after operation. And the PCA press frequency and drug consumption were recorded.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data

NCT06290024

Pain

RECRUITING

Pain Neuroscience Education in Old Adults.

NCT03523949

Healthy

UNKNOWN NA

Neural and Psychological Mechanisms of Pain Perception

NCT02446262

Pain Normal Physiology Healthy Volunteers

RECRUITING NA

Neurophysiological Characterization of Postherniotomy Pain

NCT00719368

Postoperative Pain Postherniotomy Pain Neuropathic Pain

COMPLETED

Investigating Biological Targets, Markers, and Intervention for Chronic Pain

NCT04625504

Chronic Pain Pain, Chronic Pain Syndrome +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with the following diseases were excluded: known history of chronic pain, psychiatric diseases or communication disorders, diabetes mellitus, severe cardiovascular diseases, kidney or liver diseases with poor hepatic function, alcohol or drug abuse, heavy smoker, pregnancy or at the lactation period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Surgery

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mutant alleles

grouped by SCN9A mutant alleles including 3312T, 1719R, 1150W.

No interventions assigned to this group

wild-type alleles

grouped by SCN9A wild-type alleles including 3312G, 1719C, 1150R.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 20-70 years
* Receiving elective upper abdominal surgery
* Anesthesiologists (ASA) physical status I or II
* Received PCA administration
* Agreed to participate the research

Exclusion Criteria

* History of chronic pain
* Psychiatric diseases
* Diabetes mellitus
* Severe cardiovascular diseases
* Kidney or liver diseases
* Alcohol or drug abuse
* Heavy smoker
* Pregnancy or at lactation period
* Refused PCA administration
* Disagree to participate to the research

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No